4-(2-Methylphenyl)pyridine-2-carboxylic acid
|
- $378.2 - $708
- Product name: 4-(2-Methylphenyl)pyridine-2-carboxylic acid
- CAS: 1255634-33-3
- MF: C13H11NO2
- MW: 213.23
- EINECS:
- MDL Number:MFCD14666489
- Synonyms:4-(2-Methylphenyl)pyridine-2-carboxylic acid;4-(o-tolyl)picolinic acid;2-Pyridinecarboxylic acid, 4-(2-methylphenyl)-;4-(2-Methylphenyl)-2-pyridinecarboxylic acid
4 prices
Selected condition：
Brand
- AK Scientific
- Atlantic Research Chemicals
- Crysdot
- Matrix Scientific
Package
- 1g
- 1gm:
- ManufacturerAK Scientific
- Product number3225AD
- Product description4-(2-Methylphenyl)pyridine-2-carboxylicacid
- Packaging1g
- Price$708
- Updated2021-12-16
- Buy
- ManufacturerAtlantic Research Chemicals
- Product numberCA002320
- Product description4-(2-Methylphenyl)pyridine-2-carboxylicacid 95%
- Packaging1gm:
- Price$378.2
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11314782
- Product description4-(o-Tolyl)picolinicacid 95+%
- Packaging1g
- Price$459
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number082430
- Product description4-(2-Methylphenyl)pyridine-2-carboxylic acid 97%
- Packaging1g
- Price$488
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 3225AD | 4-(2-Methylphenyl)pyridine-2-carboxylicacid | 1g | $708 | 2021-12-16 | Buy |
| Atlantic Research Chemicals | CA002320 | 4-(2-Methylphenyl)pyridine-2-carboxylicacid 95% | 1gm: | $378.2 | 2021-12-16 | Buy |
| Crysdot | CD11314782 | 4-(o-Tolyl)picolinicacid 95+% | 1g | $459 | 2021-12-16 | Buy |
| Matrix Scientific | 082430 | 4-(2-Methylphenyl)pyridine-2-carboxylic acid 97% | 1g | $488 | 2021-12-16 | Buy |
Properties
Boiling point :391.9±30.0 °C(Predicted)
Density :1.206±0.06 g/cm3(Predicted)
pka :0.98±0.50(Predicted)
Density :1.206±0.06 g/cm3(Predicted)
pka :0.98±0.50(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|